Welcome to Mundipharma

This website is intended to provide information for Mundipharma’s global business. Please visit our regional websites for access to regional and country specific information.

About Us


As a global network of independent associated companies, we put healthcare professionals and the patients they serve, at the heart of everything we do, advancing affordable treatment options, in areas of high unmet need.

Founded almost 70 years ago, we have a diverse and growing global portfolio of medicines in specialist therapy areas including Analgesia, Anti-fungals, Biosimilars, Diabetes, Oncology, Ophthalmology, Pain, Respiratory, and Consumer Health.

Latest News

Marc Princen appointed new Global CEO for Mundipharma

Jun 12 2020

Mundipharma donates BETADINE® products to hospitals in Philippines, Thailand and Vietnam to support the fight against COVID-19

Apr 07 2020

Over 4,000 employees

Presence in 124 countries

Revenues in excess of $2 billion

Regional websites

For more information please visit our regional websites

“Mundipharma is at an exciting point in its transformational journey. One focussed on creating a culture of innovation and differentiation, where every individual employee counts and can make a real difference.”
Marc Princen, Global CEO